probenecid has been researched along with Diabetic Retinopathy in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engler, CB | 1 |
| Sander, B | 1 |
| Larsen, M | 1 |
| Koefoed, P | 1 |
| Parving, HH | 1 |
| Lund-Andersen, H | 1 |
1 trial available for probenecid and Diabetic Retinopathy
| Article | Year |
|---|---|
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Topics: Adult; Biological Transport, Active; Blood; Blood-Retinal Barrier; Capillary Permeability; Cross-Ove | 1994 |